Hypoxia during air travel in adults with pulmonary disease

American Journal of the Medical Sciences

Volumn 335, Issue 1, 2008, Pages 71-79

  Mohr, Lawrence C ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Air travel; Altitude; Hypoxia; Pulmonary disease

Indexed keywords

ALTITUDE; ANEMIA; ARTERIAL OXYGEN TENSION; ARTICLE; ASTHMA; AVIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FLIGHT; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXIA; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; MEDICAL ASSESSMENT; OXYGEN SATURATION; OXYGEN SUPPLY; PATIENT CARE; PHYSIOLOGICAL STRESS; PNEUMOTHORAX; PULMONARY HYPERTENSION; PULSE OXIMETRY; SIMULATION;

EID: 38349027064     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31815f1e35     Document Type: Article

References (70)

1. Aerospace Medical Association, Air Transport Medicine Committee. Medical guidelines for air travel, 2nd Edition. Aviat Space Environ Med 2003;74:A1-19.
2. British Thoracic Society Standards of Care Committee. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2002;57:289-304.
3. Mortazavi MJ, Eisenberg MJ, Langleben D, et al. Altitude-related hypoxia: risk assessment and management for passengers on commercial aircraft. Aviat Space Environ Med 2003;74:922-7.
4. Select Committee on Science and Technology. Air travel and health: fifth report. London: United Kingdom House of Lords; November 15, 2000.
5. Gendreau MA, DeJohn C. Responding to medical events during commercial airline flights. N Engl J Med 2002;346:1067-3.
6. Datamonitor Plc. Airlines industry profile: global. London: Charles House, Datamonitor Europe; 2004.
7. Goodwin T. In-flight medical emergencies: an overview. BMJ 2000;321:1338.
8. Delaune EF, Lucas RH, Illig P. In-flight medical events and aircraft diversions: one airline's experience. Aviat Space Environ Med 2003;74:62-8.
9. Cummins RO, Schubach JA. Frequency and types of medical emergencies among commercial air travelers. JAMA 1989;261:1295-9.
10. Barclay WR. Obstructive lung disease and altitude adaptation. JAMA 1978;240:1520.
11. Dillard TA, Berg BW, Rajagopal KR, et al. Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989;111:362-7.
12. Gong H, Tashkin DP, Lee EY, et al. Hypoxia-altitude simulation test: evaluation of patients with chronic airway obstruction. Am Rev Respir Dis 1984;130:980-6.
13. Gong H. Air travel in patients with chronic obstructive pulmonary disease. Ann Intern Med 1984;100:595-7.
14. Gong H. Advising COPD patients about commercial air travel. J Resp Dis 1990;11:4844-99.
15. Matthys H, Volz H, Ernst H, et al. Kardiopulmonale belastung von flugpassagieren mit obstruktiven ventilationssstorungen. Schweiz Med Wschr 1974;104:1786-9.
16. Mohr LC. Hypoxia and Air Travel. In: Houston CS, Coates G, eds. Hypoxia: Women at Altitude. Burlington, VT: Queen City Printers; 1997:422-41.
17. Schwartz JS, Bencowitz HZ, Moser KM. Air travel hypoxemia with chronic obstructive pulmonary disease. Ann Intern Med 1984;100:473-7.
18. Tomashefski JF, Shillito FH, Billings CE, et al. Effects of moderate altitude on patients with pulmonary and cardiac impairment. Calif Med 1964;101:358-62.
19. Morgan MDL. Air travel and respiratory disease. BMJ 2002;325:1186-7.
20. DeHart RL. Health issues of air travel. Annu Rev Public Health 2003;24:133-51.
21. Mills FJ, Harding RM. Fitness to travel by air, I: physiological considerations. Br Med J 1983;286:1269-71.
22. Mills FJ, Harding RM. Fitness to travel by air, II: specific medical considerations. Br Med J 1983;286:1340-1.
23. Parkins KJ, Poets CF, O'Brien LM, et al. Effect of exposure to 15% oxygen on breathing patterns and oxygen saturation in infants: interventional study. BMJ 1998;316:887-94.
24. Buchdahl RM, Babiker A, Bush A, et al. Predicting hypoxaemia during flights in children with cystic fibrosis. Thorax 2001;56:877-9.
25. Lee AP, Yamamoto LG, Relles NL. Commercial airline travel decreases oxygen saturation in children. Pediatr Emerg Care 2002;18:78-80.
26. Samuels MP. The effects of flight and altitude. Arch Dis Child 2004;89:448-55.
27. Buchdahl R, Bush A, Ward S, et al. Preflight hypoxic challenge in infants and young children with respiratory disease. Thorax 2004;59:1000.
28. Harding RM. The earth's atmosphere. In: Ernsting J, King P, eds. Aviation Medicine. 2nd ed. London: Butterworths; 1988:3-12.
29. Heimbach RD, Sheffield PJ. Protection in the pressure environment: Cabin pressurization and oxygen equipment. In: DeHart RL, ed. Fundamentals of Aerospace Medicine. Philadelphia: Lea and Febiger; 1985;110-31.
30. Macmillan AJF. The pressure cabin. In: Ernsting J, King P, eds. Aviation Medicine. London: Butterworths; 1988:112-26.
31. Seccombe L, Kelly P, Peters M. Directly measured cabin pressure conditions on commercial aircraft. Respirology 2004;9:A66.
32. Seccombe L, Kelly P, Rogers P, et al. Current altitude simulation tests do not simulate actual cabin pressure conditions on Boeing 747 aircraft. Eur Respir J 2005;26(Suppl 49):698s.
33. Cottrell JJ. Altitude exposures during aircraft flight. Chest 1988;92:82-4.
34. Loft UC. Aviation physiology: the effect of altitude. In: Fenn WO, Rahn H, eds. Handbook of Physiology. Washington: American Physiological Society; 1965:1099-133.
35. Sheffield PJ, Heimbach RD. Respiratory physiology. In: DeHart RL, ed. Fundamentals of Aerospace Medicine. Philadelphia: Lea and Febiger; 1985:72-109.
36. Ward MP, Millege JS, West JB. Ventilatory response to hypoxia and carbon dioxide. In: High Altitude Medicine and Physiology. 3rd edition. London: Arnold; 2003:50-64.
37. Hirshman CA, McCullough RE, Weil JV. Normal values for hypoxic and hypercapnic ventilatory drives in man. J Appl Physiol 1975;38:1095-8.
38. Weil JV, Zwillich CW. Assessment of ventilatory response to hypoxia: methods and interpretation. Chest 1976;70:124-8.
39. Luks AM, Swenson ER. Travel to high altitude with preexisting lung disease. Eur Resp J 2007;29:770-92.
40. Ward MP, Millege JS, West JB. Cardiovascular system. In: High Altitude Medicine and Physiology. 3rd edition. London: Arnold; 2003:81-96.
41. Code of Federal Regulations. Title 14, part 25.841. Washington: US Government Printing Office; 1986.
42. Muhm JM, Rock PB, McMullin DL, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med 2007;357:18-27.
43. Gong H. Air travel and oxygen therapy in cardiopulmonary patients. Chest 1992;101:1104-13.
44. Dillard TA, Beninati WA, Berg BW. Air travel in patients with chronic obstructive pulmonary disease. Arch Intern Med 1991;151:1793-5.
45. Rennie ID. Medical hazards of air travel. Br Med J 1977;2:515.
46. Shesser R. Medical aspects of commercial air travel. Am J Emerg Med 1989;7:216-26.
47. Seccombe LM, Kelly PT, Wong CK, et al. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive lung disease. Thorax 2004;59:966-70.
48. Gong H, Mark JA, Cowan MN. Preflight medical screening of patients: analysis of health and flight characteristics. Chest 1993;104:788-94.
49. Dillard TA, Moores LK, Bilello KL, et al. The preflight evaluation: a comparison of the hypoxia inhalation test with hypobaric exposure. Chest 1995;107:352-7.
50. American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
51. Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med 2006;100:1573-8.
52. Enright PL, Sherrill DL. Reference equations for the sixminute walk in health adults. Am J Respir Crit Care Med 1998;158:1384-7.
53. Chetta A, Castagnetti C, Aiello M, et al. Walking capacity and fitness to fly in patients with chronic respiratory disease. Aviat Space Environ Med 2007;78:789-92.
54. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Respir Crit Care Med 1995;152(Suppl);S77-120.
55. Lyznicki JM, Williams MA, Deitchman SD, et al. Medical oxygen and air travel. Aviat Space Environ Med 2000;71:827-31.
56. Johnson AOC. Chronic obstructive pulmonary disease-11: fitness to fly with COPD. Thorax 2003;58:729-32.
57. Christensen CC, Ryg M, Refvem OK, et al. Development of severe hypoxemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. Eur Respir J 2000;15:635-9.
58. Akero A, Christensen CC, Edvardsen Skjonsberg OH. Hypoxemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J 2005;25:725-30.
59. Seccombe LM, Peters MJ. Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel. Curr Opin Pulm Med 2006;12:140-4.
60. Berg BW, Dillard TA, Rajagopal KR, et al. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest 1992;101:638-41.
61. Mohr LC. Arterial oxygen tension at moderate altitude: a multivariate model for chronic obstructive lung disease [abstract]. In: Sutton JR, Houston CS, Coates G, eds. Hypoxia and the Brain. Burlington, VT: Queen City Printers; 1995:332.
62. Christensen CC, Ryg MS, Refvem OK, et al. Effect of hypobaric hypoxia on blood gasses in patients with restrictive lung disease. Eur Respir J 2002;20:300-5.
63. Alpert JS, Irwin RS, Dalen JA. Pulmonary hypertensive heart disease. In: Stein JH, ed. Internal Medicine. 4th edition. St. Louis: Mosby; 1994:277-85.
64. Rounds S, Hill NS. Pulmonary hypertensive diseases. Chest 1984;85:397-405.
65. American Medical Association. Medical aspects of transportation aboard commercial aircraft. JAMA 1982;247:1007-11.
66. Fuchs HS. Idiopathic spontaneous pneumothorax and flying: with particular reference to the etiological role of decreased atmospheric pressure, pressure breathing, increased gravitational forces, and anti-G-suit action. Aerospace Med 1967;38:1283-5.
67. Cheatham ML, Safcsak K. Air travel following traumatic pneumothorax: when is it safe? Am Surg 1999;65:1160-4.
68. Lippert HL, Lund O, Blegvad S, et al. Independent risk factors for cumulative recurrence rate after first spontaneous pneumothorax. Eur Respir J 1991;4:324-31.
69. Department of Transportation. Federal Aviation Administration. 14 CFR 11 and 121. Use of certain portable oxygen concentrator devices on board aircraft: final rule. Federal Register; July 12, 2005:70;132.
70. Department of Transportation. Federal Aviation Administration. 14 CFR 11 and 121. Use of additional portable oxygen concentrator devices onboard aircraft: final rule. Federal Register; September 12, 2006:71;176.